State of Alaska Department of Revenue Has $895,000 Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

State of Alaska Department of Revenue grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 1.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,136 shares of the company’s stock after purchasing an additional 180 shares during the period. State of Alaska Department of Revenue’s holdings in HealthEquity were worth $895,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Sanctuary Advisors LLC increased its holdings in HealthEquity by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock worth $320,000 after buying an additional 159 shares during the last quarter. First Horizon Advisors Inc. raised its stake in HealthEquity by 50.7% in the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock valued at $107,000 after purchasing an additional 375 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after purchasing an additional 100 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in HealthEquity by 2.1% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 70,592 shares of the company’s stock valued at $6,773,000 after purchasing an additional 1,453 shares in the last quarter. Finally, Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the fourth quarter worth approximately $39,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 0.9%

HQY stock opened at $104.86 on Friday. The company has a market capitalization of $9.07 billion, a price-to-earnings ratio of 76.54, a PEG ratio of 1.59 and a beta of 0.49. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The business has a 50 day simple moving average of $97.61 and a two-hundred day simple moving average of $97.93. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the prior year, the firm posted $0.80 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analysts Set New Price Targets

HQY has been the topic of several analyst reports. Barrington Research lifted their target price on shares of HealthEquity from $112.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, June 5th. Royal Bank Of Canada lifted their price target on HealthEquity from $112.00 to $117.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 4th. KeyCorp lowered their price target on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Raymond James Financial raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $98.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, June 5th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $118.09.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company’s stock, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the firm’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president now directly owns 75,689 shares of the company’s stock, valued at approximately $8,519,553.84. This represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 304,581 shares of company stock worth $33,664,018 over the last quarter. Company insiders own 1.50% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.